Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$269.99
▼ $0.23 (−0.09%) today
Markets closed · 4:56am ET

JNJ Coverage

Page 94
6:55am ET
Investing

Johnson & Johnson (JNJ) Revenue Up On Pfizer Unit Purchase

Johnson & Johnson’s (JNJ) revenue rose 13% to $15.1 billion in Q2. However, if revenue from the purchase of Pfizer’s consumer healthcare business was accounted for, the topline would have been up…

JNJ
Douglas A. McIntyre
9:31am ET
Investing

Results-Based Pharma (JNJ)(GSK)

Imagine that if an aspirin did not get rid of you headache. And, the company that made the pain killer gave you your money back. A new proposal by Johnson & Johnson…

Douglas A. McIntyre
4:58pm ET
Investing

Top Earnings Next Week Part 1 (July 16-18, 2007)

MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM Corp. (NYSE:SLR)State Street (NYSE:STT)Coca Cola (NYSE:KO)Wells fargo (NYSE:WFC)Yahoo! (NASDAQ:YHOO) WEDNESDAYAbbott Labs (NYSE:ABT)Altria…

Douglas A. McIntyre
1:35pm ET
Investing

Conoco (COP) Tops JNJ, Sets $15 Billion Share Buy-Back

Not many hours after Johnson & Johnson (JNJ) announced its $10 billion share buy-back, ConocoPhillips (COP) decided it would not be bested. It announced a $15 billion share repurchase program of its…

Douglas A. McIntyre
12:49pm ET
Investing

Johnson & Johnson (JNJ): No More Worlds To Conquer

In a sign that it is still struggling as competition emerges for it major drugs Procrit and Risperdal and that its stent business is still troubled by safety concerns, Johnson & Johnson…

JNJ
Douglas A. McIntyre
5:17pm ET
Media

Cramer Reviews 10 Warren Buffett Stock Picks

Stock Tickers: BRK/A, BNI, KO, PG, WMT, USG, AXP, WFC, MCO, JNJ, COP On tonight’s MAD MONEY on CNBC, Jim Cramer reviewed another Warren Buffett strategy by reviewing holdings to see if…

Douglas A. McIntyre
5:53pm ET
Health and Healthcare

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks.  He’d rather focus…

Douglas A. McIntyre
6:19am ET
Investing

Earlybird Analyst Calls (June 11, 2007)

AGP raised to Hold at Jefferies.ARAY started as Underperform at CIBC.BE cut to Underperform at Jefferies.BF/a raised to Overweight at JPMorgan.BOT cut to Neutral at Credit Suisse.CAVM started as Buy at Deutsche…

Douglas A. McIntyre
6:30pm ET
Health and Healthcare

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing a muted…

Douglas A. McIntyre
5:25pm ET
Investing

DJIA Components Huge Rise in Short Selling (MAY-07)

We reviewed various short selling trends and noticed that most sectors were mixed to up as the April to May reached record levels.  But reviewing the 28 Dow Jones Industrial Average components…

Douglas A. McIntyre
4:36pm ET
Health and Healthcare

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is…

Douglas A. McIntyre